Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo.
about
Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targetsCalcineurin Targets Involved in Stress Survival and Fungal VirulenceAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisThe triphenylethylenes, a novel class of antifungals.Oral administration of the broad-spectrum antibiofilm compound toremifene inhibits Candida albicans and Staphylococcus aureus biofilm formation in vivo.Structure-activity relationships for the antifungal activity of selective estrogen receptor antagonists related to tamoxifenRising to the challenge of multiple Cryptococcus species and the diseases they cause.Antagonism of Fluconazole and a Proton Pump Inhibitor against Candida albicans.Cryptococcus: from environmental saprophyte to global pathogen.Antifungal adjuvants: Preserving and extending the antifungal arsenalDrug repurposing screens and synergistic drug-combinations for infectious diseases.Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.The antifungal pipeline: a reality check.Investigation of aryl isonitrile compounds with potent, broad-spectrum antifungal activity.Repurposing Toremifene for Treatment of Oral Bacterial Infections.Unraveling the biology of a fungal meningitis pathogen using chemical genetics.New Horizons in Antifungal Therapy.Discovery of a Novel Dibromoquinoline Compound Exhibiting Potent Antifungal and Antivirulence Activity That Targets Metal Ion Homeostasis.An Overview of Sex Bias in C. neoformans Infections.Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.Present and Future Therapy of Infections
P2860
Q28080558-45FEE9E9-9351-4CEE-A34D-54AB54213834Q28553977-DFF99528-79D7-4119-B383-352807BC41AEQ28818603-ADB2F6DA-D7F5-44FA-80AE-898712D924D3Q33569534-0E24C22C-BF50-4AE0-B231-E4999DED88D1Q34597915-D771E84B-C895-4A55-8DA6-CD2B3D45216DQ35643319-063F8955-EEA8-4CEB-96E5-2F625F13E476Q35706177-19FDFE48-804A-46A2-8B5F-BFD0AE0CF21CQ36571941-10974D44-90D9-45CD-99EE-E3986B7F8B99Q37250158-04615626-3F13-4159-8586-99659B02C81CQ37705308-BFA9EDC3-546E-4835-8453-7110F14E78C9Q38158092-60BDCDC6-4F93-47EF-87B4-39831BCC2EC2Q38851467-B4909A5B-3582-47C2-A0CA-CC6749305309Q39299949-28BEB5C5-057F-4A82-91D2-5F6FBD9E5C75Q40261514-092253BD-5FFC-4E23-B62A-B54D9E9A9E00Q40403765-0D90FF5C-C25C-4C53-B77C-572C81851D9AQ41652452-9965B674-5E5D-403D-8378-532F55C332CFQ48149179-3E993E11-4D18-466D-B8D2-B935DD75CCE0Q48164716-C9144D57-6B60-4696-BCAA-E9C2729A6B28Q53280529-A6F6BE12-5420-4A61-A18F-D1AE747DF49EQ55229762-F349F92E-4C3D-458E-93D5-8B248885E87AQ57177336-61058089-088A-45FE-B63A-76BE41E96E9B
P2860
Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Estrogen receptor antagonists ...... gize with fluconazole in vivo.
@ast
Estrogen receptor antagonists ...... gize with fluconazole in vivo.
@en
type
label
Estrogen receptor antagonists ...... gize with fluconazole in vivo.
@ast
Estrogen receptor antagonists ...... gize with fluconazole in vivo.
@en
prefLabel
Estrogen receptor antagonists ...... gize with fluconazole in vivo.
@ast
Estrogen receptor antagonists ...... gize with fluconazole in vivo.
@en
P2093
P2860
P50
P356
P1433
P1476
Estrogen receptor antagonists ...... gize with fluconazole in vivo.
@en
P2093
Arielle Butts
Camile P Semighini
Jessica C S Brown
Joseph Heitman
Julie Tabroff
Kristy Koselny
Louis DiDone
Magid Abou-Gharbia
Maria E Cardenas
Sivakumar Annadurai
P2860
P304
P356
10.1128/MBIO.00765-13
P577
2014-02-11T00:00:00Z